BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Anthera Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial Report and Conference Call

  October 27, 2010

   · 

  1 min read
• Drug Development

  Intellect Neurosciences, Inc. Obtains OX1 Phase 1b Draft Report Showing the Company’s Lead Alzheimer’s Candidate Was Safe and Well-Tolerated at All Dose Levels Tested

  October 27, 2010

   · 

  1 min read
• Novel SERM Lasofoxifene Reduces CHD Events in Postmenopausal Women

  October 27, 2010

   · 

  1 min read
• Business

  RedPath Integrated Pathology, Inc. Terminates Deal with ExonHit Therapeutics SA

  October 27, 2010

   · 

  1 min read
• High Resting Heart Rate Linked to Shorter Life Expectancy in Stable HD Patients

  October 27, 2010

   · 

  1 min read
• Study Identifies Potential Stroke Triggers

  October 27, 2010

   · 

  1 min read
• Business

  Incyte Corporation to Report Third Quarter 2010 Financial Results and Provide Update on Drug Discovery & Development Programs on November 9

  October 27, 2010

   · 

  1 min read
• Genetown

  ArQule, Inc. to Present at Oppenheimer 21st Annual Healthcare Conference

  October 27, 2010

   · 

  1 min read
• Business

  PPD, Inc. Reports Third Quarter 2010 Financial Results

  October 27, 2010

   · 

  1 min read
• Drug Development

  Presidio Pharmaceuticals, Inc. to Present First Clinical Data for PPI-461, a New HCV NS5A inhibitor, at the American Association for the Study of Liver Diseases (AASLD) Meeting, Supporting Initiation of a Trial in Hepatitis C Patients

  October 27, 2010

   · 

  1 min read